InflaRx (IFRX) Change in Receivables (2024 - 2026)
InflaRx's (IFRX) quarterly Change in Receivables came in at $1.2 million in Q2 2026, up 5425.5% year-over-year from $20893.5 in Q2 2025, and up 706.31% quarter-over-quarter from -$190408.9 in Q1 2026.
Analysis
InflaRx (IFRX) Change in Receivables (2024 - 2026) Analysis & Trends
InflaRx has disclosed Change in Receivables across 3 years of filings, most recently posting $1.2 million for Q2 2026.
- In Q2 2026, Change in Receivables rose 5425.5% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $4.0 million (up 803.67% YoY), while the FY2025 annual figure was $2.5 million, up 123.35% from the prior year.
- Change in Receivables came in at $1.2 million for Q2 2026 at InflaRx, up from -$190408.9 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $3.1 million in Q4 2025 to a low of -$867205.8 in Q4 2024.
- Average Change in Receivables over 3 years is $471361.7, with a median of -$48451.1 recorded in 2025.
- Year-over-year, Change in Receivables sank 132.92% in 2025 and soared 5425.5% in 2026.
- Over 3 years, Change in Receivables stood at -$867205.8 in 2024, then soared by 459.06% to $3.1 million in 2025, then sank by 62.92% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $1.2 million in Q2 2026, -$190408.9 in Q1 2026, and $3.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.09 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 333.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 140.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 838.50 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -53.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 269.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | 1.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Mn |
| Mar 31, 2026 | -190,408.90 |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | -75,224.02 |
| Jun 30, 2025 | -21,678.16 |
| Mar 31, 2025 | -409,380.80 |
| Dec 31, 2024 | -867,205.77 |
| Sep 30, 2024 | 729,439.59 |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | -175,761.38 |